REPORT DESCRIPTION
Acute Invasive Aspergillosis Treatment Market – Overview
According to the Centers for Disease Control and Prevention, the epidemiology of invasive aspergillus
infection is dependent upon increasing number of solid organ transplants, stem cell transplant, and newer
immunosuppressive agents, 2017. According to Organ Procurement and Transplantation Network (OPTN),
around 8,500 organ transplants have been performed in 2018 and the number is expected to grow in the
near future. These factors are expected to support the growth of the acute invasive aspergillosis treatment
market. Patients who undergo organ transplant procedure are often prescribed immunosuppressant
medications, which increases their susceptibility to aspergillosis infection. Similarly, patients in the
advanced stages of AIDS are also highly susceptible to opportunistic infections such as aspergillosis.
According to the World Health Organization (WHO), around 36.7 million people were found suffering
from HIV in 2016. Extended use of corticosteroids further weakens the immune system, thus increasing the
risk of developing such infections. This in turn, is increasing the demand for acute invasive aspergillosis
treatment over the forecast period.